Document is current
Any future updates will be listed below
-
Authors
Koca, Nizameddin https://orcid.org/0000-0003-1457-4366
Uyar, Seyit https://orcid.org/0000-0002-2435-8248
Şahintürk, Yasin https://orcid.org/0000-0003-4907-0766
Yıldız, Hamit https://orcid.org/0000-0001-7858-5123
Del Prato, Stefano https://orcid.org/0000-0001-5905-0211
DeFronzo, RalphA. https://orcid.org/0000-0002-8581-6273
- License Information
-
More Information
Article History
Received: 9 July 2026
Accepted: 17 August 2026
First Online: 26 August 2026
Declarations
Ethics approval and consent to participate: Not applicable.
Consent for publication: Not applicable.
Competing Interests: N.K., S.U., Y.Ş., H.Y., and R.A.D. declare no competing interests. S.D.P. reports consulting fees from Abbott, Altimmune, Applied Therapeutics, Biomea Fusion, Eli Lilly and Company, Menarini International, Hoffman-La Roche, Novo Nordisk, and Sun Pharma; and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Abbott, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Menarini International, Novo Nordisk, and Sanofi.
